{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34956377", "DateRevised": {"Year": "2021", "Month": "12", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["3730963", "10.1155/2021/3730963"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment.", "Pagination": {"StartPage": "3730963", "MedlinePgn": "3730963"}, "Abstract": {"AbstractText": ["Among all malignant tumors in the whole universe, the incidence and mortality of lung cancer disease rank first. Especially in the past few years, the occurrence of lung cancer in the urban population has continued to increase, which seriously threatens the lives and health of people. Among the many treatments for lung cancer, chemotherapy is the best one, but traditional chemotherapy has low specificity and drug resistance. To address the above issue, this study reviews the five biological pathways that common terpenoid compounds in medicinal plants interfere with the occurrence and development of lung cancer: cell proliferation, cell apoptosis, cell autophagy, cell invasion, metastasis, and immune mechanism regulation. In addition, the mechanism of the terpenoid natural traditional Chinese medicine monomer compound combined with Western medicine in the multipathway antilung cancer is summarized."], "CopyrightInformation": "Copyright \u00a9 2021 Heng Sun et al."}, "AuthorList": [{"Identifier": ["0000-0001-6009-5812"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology, Harbin, China."}, {"Identifier": [], "Affiliation": "Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Sun", "ForeName": "Heng", "Initials": "H"}, {"Identifier": ["0000-0002-5728-6586"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology Ethics Office, Harbin, China."}], "LastName": "Zhang", "ForeName": "Lijia", "Initials": "L"}, {"Identifier": ["0000-0002-8452-3954"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology Respiratory, Harbin, China."}], "LastName": "Sui", "ForeName": "Bowen", "Initials": "B"}, {"Identifier": ["0000-0002-6853-2236"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology, Harbin, China."}], "LastName": "Li", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology, Harbin, China."}], "LastName": "Yan", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology, Harbin, China."}], "LastName": "Wang", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Academic Affairs Section, Harbin, China."}], "LastName": "Wang", "ForeName": "Ye", "Initials": "Y"}, {"Identifier": ["0000-0002-7214-8464"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Oncology, Harbin, China."}], "LastName": "Liu", "ForeName": "Songjiang", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nasim F., Sabath B. F., Eapen G. A. Lung cancer. Medical Clinics of North America . 2019;103(3):463\u2013473. doi: 10.1016/j.mcna.2018.12.006.", "ArticleIdList": ["10.1016/j.mcna.2018.12.006", "30955514"]}, {"Citation": "Wu W., Wang X., Shan C., Li Y., Li F. Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma. OncoTargets and Therapy . 2018;11:5025\u20135034. doi: 10.2147/OTT.S169002.", "ArticleIdList": ["10.2147/OTT.S169002", "PMC6109654", "30174440"]}, {"Citation": "Naz I., Ramchandani S., Khan M. R., Yang M. H., Ahn K. S. Anticancer potential of raddeanin A, a natural triterpenoid isolated from anemone raddeana regel. Molecules . 2020;25(5):p. 1035. doi: 10.3390/molecules25051035.", "ArticleIdList": ["10.3390/molecules25051035", "PMC7179125", "32106609"]}, {"Citation": "Liu M., Wang X., Li H., et al. The effect of apatinib combined with chemotherapy or targeted therapy on non\u2010small cell lung cancer in vitro and vivo. Thoracic Cancer . 2019;10(10):1868\u20131878. doi: 10.1111/1759-7714.13162.", "ArticleIdList": ["10.1111/1759-7714.13162", "PMC6775003", "31486270"]}, {"Citation": "Ramsay R. R., Popovic-Nikolic M. R., Nikolic K., Uliassi E., Bolognesi M. L. A perspective on multi-target drug discovery and design for complex diseases. Clinical and Translational Medicine . 2018;7(1):p. 3. doi: 10.1186/s40169-017-0181-2.", "ArticleIdList": ["10.1186/s40169-017-0181-2", "PMC5770353", "29340951"]}, {"Citation": "Yumura M., Nagano T., Nishimura Y. Novel multitarget therapies for lung cancer and respiratory disease. Molecules . 2020;25(17):p. 3987. doi: 10.3390/molecules25173987.", "ArticleIdList": ["10.3390/molecules25173987", "PMC7504797", "32882995"]}, {"Citation": "Wen C., Xu G., He S., et al. Screening circular RNAs related to acquired gefitinib resistance in non-small cell lung cancer cell lines. Journal of Cancer . 2020;11(13):3816\u20133826. doi: 10.7150/jca.39783.", "ArticleIdList": ["10.7150/jca.39783", "PMC7171488", "32328186"]}, {"Citation": "Wu K., Guo C., Li R. Clinical characterization of icotinib-induced chemoresistance in erlotinib-treated lung adenocarcinoma patient with EGFR mutations. Medicine . 2019;98(18):p. e15489. doi: 10.1097/MD.0000000000015489.", "ArticleIdList": ["10.1097/MD.0000000000015489", "PMC6504272", "31045832"]}, {"Citation": "Zhong L., Li Y., Xiong L., et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy . 2021;6(1):p. 201. doi: 10.1038/s41392-021-00572-w.", "ArticleIdList": ["10.1038/s41392-021-00572-w", "PMC8165101", "34054126"]}, {"Citation": "Luo H., Vong C. T., Chen H., et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chinese Medicine . 2019;14(1):p. 48. doi: 10.1186/s13020-019-0270-9.", "ArticleIdList": ["10.1186/s13020-019-0270-9", "PMC6836491", "31719837"]}, {"Citation": "Wan L.-Q., Tan Y., Jiang M., Hua Q. The prognostic impact of traditional Chinese medicine monomers on tumor-associated macrophages in non-small cell lung cancer. Chinese Journal of Natural Medicines . 2019;17(10):729\u2013737. doi: 10.1016/S1875-5364(19)30089-5.", "ArticleIdList": ["10.1016/S1875-5364(19)30089-5", "31703753"]}, {"Citation": "Guti\u00e9rrez-Escribano P., Nurse P. A single cyclin-CDK complex is sufficient for both mitotic and meiotic progression in fission yeast. Nature Communications . 2015;6(1):p. 6871. doi: 10.1038/ncomms7871.", "ArticleIdList": ["10.1038/ncomms7871", "PMC4411289", "25891897"]}, {"Citation": "Lane D. Development of CDK inhibitors as cancer therapeutics. Breast Cancer Research . 2005;7(S2):p. 38. doi: 10.1186/bcr1081.", "ArticleIdList": ["10.1186/bcr1081"]}, {"Citation": "Zhao S., Yang X.-f., Shen D.-f., et al. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy. Oncotarget . 2016;7(34):54596\u201354615. doi: 10.18632/oncotarget.10519.", "ArticleIdList": ["10.18632/oncotarget.10519", "PMC5342367", "27409347"]}, {"Citation": "Zhong Y.-H., Cheng H.-Z., Peng H., Tang S.-C., Wang P. Heat shock factor 2 is associated with the occurrence of lung cancer by enhancing the expression of heat shock proteins. Oncology Letters . 2016;12(6):5106\u20135112. doi: 10.3892/ol.2016.5368.", "ArticleIdList": ["10.3892/ol.2016.5368", "PMC5228092", "28101237"]}, {"Citation": "Luo X., Luo W., Lin C., Zhang L., Li Y. Andrographolide inhibits proliferation of human lung cancer cells and the related mechanisms. International Journal of Clinical and Experimental Medicine . 2014;7(11):4220\u20134225.", "ArticleIdList": ["PMC4276192", "25550934"]}, {"Citation": "Luo W., Liu Y., Zhang J., Luo X., Lin C., Guo J. Andrographolide inhibits the activation of NF-\u03baB and MMP-9 activity in H3255 lung cancer cells. Experimental and therapeutic medicine . 2013;6(3):743\u2013746. doi: 10.3892/etm.2013.1196.", "ArticleIdList": ["10.3892/etm.2013.1196", "PMC3786803", "24137258"]}, {"Citation": "Huang R.-Y., Chu Y.-L., Huang Q.-C., et al. 18\u03b2-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer. PLoS One . 2014;9(4):p. e93690. doi: 10.1371/journal.pone.0093690.", "ArticleIdList": ["10.1371/journal.pone.0093690", "PMC3973544", "24695790"]}, {"Citation": "Zhu J., Chen M., Chen N., et al. Glycyrrhetinic acid induces G1-phase cell cycle arrest in human non-small cell lung cancer cells through endoplasmic reticulum stress pathway. International Journal of Oncology . 2015;46(3):981\u2013988. doi: 10.3892/ijo.2015.2819.", "ArticleIdList": ["10.3892/ijo.2015.2819", "PMC4324580", "25573651"]}, {"Citation": "Corveloni A. C., Semprebon S. C., Baranoski A., Biazi B. I., Zanetti T. A., Mantovani M. S. Carnosic acid exhibits antiproliferative and proapoptotic effects in tumoral NCI-H460 and nontumoral IMR-90 lung cells. Journal of Toxicology and Environmental Health. Part A . 2020;83(10):412\u2013421. doi: 10.1080/15287394.2020.1767741.", "ArticleIdList": ["10.1080/15287394.2020.1767741", "32456600"]}, {"Citation": "Xiao S., Lin Z., Wang X., Lu J., Zhao Y. Synthesis and cytotoxicity evaluation of panaxadiol derivatives. Chemistry and Biodiversity . 2020;17(1):p. e1900516. doi: 10.1002/cbdv.201900516.", "ArticleIdList": ["10.1002/cbdv.201900516", "31725193"]}, {"Citation": "He C.-S., Liu Y.-C., Xu Z.-P., Dai P.-C., Chen X.-W., Jin D.-H. Astragaloside IV enhances cisplatin chemosensitivity in non-small cell lung cancer cells through inhibition of B7-H3. Cellular Physiology and Biochemistry . 2016;40(5):1221\u20131229. doi: 10.1159/000453175.", "ArticleIdList": ["10.1159/000453175", "27960166"]}, {"Citation": "Zhang J.-J., Gao T.-T., Wang Y., et al. Andrographolide exerts significant antidepressant-like effects involving the hippocampal BDNF system in mice. International Journal of Neuropsychopharmacology . 2019;22(9):585\u2013600. doi: 10.1093/ijnp/pyz032.", "ArticleIdList": ["10.1093/ijnp/pyz032", "PMC6754737", "31181145"]}, {"Citation": "Banerjee A., Banerjee V., Czinn S., Blanchard T. Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells. Oncotarget . 2017;8(16):26142\u201326153. doi: 10.18632/oncotarget.15393.", "ArticleIdList": ["10.18632/oncotarget.15393", "PMC5432246", "28412728"]}, {"Citation": "Rauchensteiner F., Matsumura Y., Yamamoto Y., Yamaji S., Tani T. Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary-zone electrophoresis (CZE) Journal of Pharmaceutical and Biomedical Analysis . 2005;38(4):594\u2013600. doi: 10.1016/j.jpba.2005.01.038.", "ArticleIdList": ["10.1016/j.jpba.2005.01.038", "15967286"]}, {"Citation": "Lin Z., Qiu S., Wufuer A., Shum L. Simultaneous determination of glycyrrhizin, a marker component in Radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC-MS/MS. Journal of Chromatography B . 2005;814(2):201\u2013207. doi: 10.1016/j.jchromb.2004.10.026.", "ArticleIdList": ["10.1016/j.jchromb.2004.10.026", "15639440"]}, {"Citation": "Barni M. V., Carlini M. J., Cafferata E. G., Puricelli L., Moreno S. Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncology Reports . 2012;27(4):1041\u20131048. doi: 10.3892/or.2012.1630.", "ArticleIdList": ["10.3892/or.2012.1630", "PMC3583532", "22246562"]}, {"Citation": "Dhuna K., Felgate M., Bidula S. M., et al. Ginsenosides act as positive modulators of P2X4 receptors. Molecular Pharmacology . 2019;95(2):210\u2013221. doi: 10.1124/mol.118.113696.", "ArticleIdList": ["10.1124/mol.118.113696", "PMC6334005", "30545933"]}, {"Citation": "Mao Q., Chen C., Liang H., Zhong S., Cheng X., Li L. Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF\u2011\u03b21/Smad/miR\u2011192 signaling pathway. Experimental and therapeutic medicine . 2019;18:3053\u20133061. doi: 10.3892/etm.2019.7887.", "ArticleIdList": ["10.3892/etm.2019.7887", "PMC6755437", "31572545"]}, {"Citation": "Schenker H., B\u00fcttner-Herold M., Fietkau R., Distel L. V. Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas. Radiation Oncology . 2017;12(1) doi: 10.1186/s13014-016-0746-z.", "ArticleIdList": ["10.1186/s13014-016-0746-z", "PMC5241920", "28100275"]}, {"Citation": "Yan X., Li F., Dozmorov I., et al. External Qi of Yan Xin Qigong induces cell death and gene expression alterations promoting apoptosis and inhibiting proliferation, migration and glucose metabolism in small-cell lung cancer cells. Molecular and Cellular Biochemistry . 2012;363(1-2):245\u2013255. doi: 10.1007/s11010-011-1176-8.", "ArticleIdList": ["10.1007/s11010-011-1176-8", "PMC3567610", "22160803"]}, {"Citation": "Cui Y., Li L., Li Z., et al. Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer. Cancer Cell International . 2021;21(1) doi: 10.1186/s12935-021-01949-1.", "ArticleIdList": ["10.1186/s12935-021-01949-1", "PMC8086328", "33931048"]}, {"Citation": "Shi P., Chen C., Li X., Wei Z., Liu Z., Liu Y. MicroRNA\u2011124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3. Molecular Medicine Reports . 2019;19(5):3667\u20133675. doi: 10.3892/mmr.2019.10044.", "ArticleIdList": ["10.3892/mmr.2019.10044", "PMC6472193", "30896795"]}, {"Citation": "Al-Alem L. F., Baker A. T., Pandya U. M., Eisenhauer E. L., Rueda B. R. Understanding and targeting apoptotic pathways in ovarian cancer. Cancers . 2019;11(11):p. 1631. doi: 10.3390/cancers11111631.", "ArticleIdList": ["10.3390/cancers11111631", "PMC6893837", "31652965"]}, {"Citation": "Liu F., Kalpage H. A., Wang D., et al. Cotargeting of mitochondrial complex I and bcl-2 shows antileukemic activity against acute myeloid leukemia cells reliant on oxidative phosphorylation. Cancers . 2020;12(9):p. 2400. doi: 10.3390/cancers12092400.", "ArticleIdList": ["10.3390/cancers12092400", "PMC7564145", "32847115"]}, {"Citation": "Hu X., Moisan J., Majchrzak K., et al. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Journal for Immunotherapy of Cancer . 2015;3(S2) doi: 10.1186/2051-1426-3-S2-P23.", "ArticleIdList": ["10.1186/2051-1426-3-S2-P23"]}, {"Citation": "Forster S., Radpour R. Molecular immunotherapy: promising approach to treat metastatic colorectal cancer by targeting resistant cancer cells or cancer stem cells. Frontiers in oncology . 2020;10:p. 569017. doi: 10.3389/fonc.2020.569017.", "ArticleIdList": ["10.3389/fonc.2020.569017", "PMC7680905", "33240813"]}, {"Citation": "Guha A., Ahuja D., Das Mandal S., et al. Integrated regulation of HuR by translation repression and protein degradation determines pulsatile expression of p53 under DNA damage. iScience . 2019;15:342\u2013359. doi: 10.1016/j.isci.2019.05.002.", "ArticleIdList": ["10.1016/j.isci.2019.05.002", "PMC6548907", "31103853"]}, {"Citation": "Liu H., Zhu Y., Zhang T., et al. Anti-tumor effects of atractylenolide I isolated from Atractylodes macrocephala in human lung carcinoma cell lines. Molecules . 2013;18(11):13357\u201313368. doi: 10.3390/molecules181113357.", "ArticleIdList": ["10.3390/molecules181113357", "PMC6270531", "24172243"]}, {"Citation": "Kang T.-H., Bang J.-Y., Kim M.-H., Kang I.-C., Kim H.-M., Jeong H.-J. Atractylenolide III, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway. Food and Chemical Toxicology . 2011;49(2):514\u2013519. doi: 10.1016/j.fct.2010.11.038.", "ArticleIdList": ["10.1016/j.fct.2010.11.038", "21130827"]}, {"Citation": "Wang Z., Zhao X., Gong X. Costunolide induces lung adenocarcinoma cell line A549 cells apoptosis through ROS (reactive oxygen species)-mediated endoplasmic reticulum stress. Cell Biology International . 2016;40(3):289\u2013297. doi: 10.1002/cbin.10564.", "ArticleIdList": ["10.1002/cbin.10564", "26609913"]}, {"Citation": "Hua P., Zhang G., Zhang Y., et al. Costunolide induces G1/S phase arrest and activates mitochondrial-mediated apoptotic pathways in SK-MES 1 human lung squamous carcinoma cells. Oncology Letters . 2016;11(4):2780\u20132786. doi: 10.3892/ol.2016.4295.", "ArticleIdList": ["10.3892/ol.2016.4295", "PMC4812560", "27073552"]}, {"Citation": "Ma J., Liu J., Lu C., Cai D. Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells. Cancer Cell International . 2015;15(1):p. 78. doi: 10.1186/s12935-015-0230-0.", "ArticleIdList": ["10.1186/s12935-015-0230-0", "PMC4524283", "26244039"]}, {"Citation": "Ling H., Jia X., Zhang Y., et al. Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Molecular Carcinogenesis . 2010;49", "ArticleIdList": ["19918789"]}, {"Citation": "Ling H., Zhou L., Jia X., Gapter L. A., Agarwal R., Ng K.-y. Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells. Molecular Carcinogenesis . 2009;48(6):498\u2013507. doi: 10.1002/mc.20487.", "ArticleIdList": ["10.1002/mc.20487", "18973184"]}, {"Citation": "Wang K., Zhan Y., Chen B., et al. Tubeimoside I-induced lung cancer cell death and the underlying crosstalk between lysosomes and mitochondria. Cell Death & Disease . 2020;11(8):p. 708. doi: 10.1038/s41419-020-02915-x.", "ArticleIdList": ["10.1038/s41419-020-02915-x", "PMC7449972", "32848130"]}, {"Citation": "Kim D. Y., Choi B. Y. Costunolide-A bioactive sesquiterpene lactone with diverse therapeutic potential. International Journal of Molecular Sciences . 2019;20(12):p. 2926. doi: 10.3390/ijms20122926.", "ArticleIdList": ["10.3390/ijms20122926", "PMC6627852", "31208018"]}, {"Citation": "Du J., Dong Z., Tan L., et al. Tubeimoside I inhibits cell proliferation and induces a partly disrupted and cytoprotective autophagy through rapidly hyperactivation of MEK1/2-ERK1/2 cascade via promoting PTP1B in melanoma. Frontiers in cell and developmental biology . 2020;8:p. 607757. doi: 10.3389/fcell.2020.607757.", "ArticleIdList": ["10.3389/fcell.2020.607757", "PMC7773826", "33392197"]}, {"Citation": "Yuwen D., Mi S., Ma Y., et al. Andrographolide enhances cisplatin-mediated anticancer effects in lung cancer cells through blockade of autophagy. Anti-Cancer Drugs . 2017;28(9):967\u2013976. doi: 10.1097/CAD.0000000000000537.", "ArticleIdList": ["10.1097/CAD.0000000000000537", "28692436"]}, {"Citation": "Mi S., Xiang G., Yuwen D., et al. Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway. Toxicology and Applied Pharmacology . 2016;310:78\u201386. doi: 10.1016/j.taap.2016.09.009.", "ArticleIdList": ["10.1016/j.taap.2016.09.009", "27639426"]}, {"Citation": "Alotaibi M. R., As Sobeai H. M., Alaqil F. A., et al. A newly synthesized platinum-based compound (PBC-II) increases chemosensitivity of HeLa ovarian cancer cells via inhibition of autophagy. Saudi Pharmaceutical Journal: The Official Publication of the Saudi Pharmaceutical Society . 2019;27(8):1203\u20131209. doi: 10.1016/j.jsps.2019.10.003.", "ArticleIdList": ["10.1016/j.jsps.2019.10.003", "PMC6921179", "31885480"]}, {"Citation": "Tang Z.-H., Zhang L.-L., Li T., et al. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1\u03b1-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells. Oncotarget . 2015;6(41):43911\u201343926. doi: 10.18632/oncotarget.6084.", "ArticleIdList": ["10.18632/oncotarget.6084", "PMC4791276", "26549806"]}, {"Citation": "Wang K., Liu X., Liu Q., et al. Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells. Cell Death & Disease . 2020;11(8):p. 611. doi: 10.1038/s41419-020-02880-5.", "ArticleIdList": ["10.1038/s41419-020-02880-5", "PMC7426971", "32792495"]}, {"Citation": "Chuang H.-H., Wang P.-H., Niu S.-W., et al. Inhibition of FAK signaling elicits lamin A/C-associated nuclear deformity and cellular senescence. Frontiers in oncology . 2019;9 doi: 10.3389/fonc.2019.00022.", "ArticleIdList": ["10.3389/fonc.2019.00022", "PMC6363943", "30761269"]}, {"Citation": "Liu H., Lu T., Kremers G.-J., Seynhaeve A. L. B., Ten Hagen T. L. M. A microcarrier-based spheroid 3D invasion assay to monitor dynamic cell movement in extracellular matrix. Biological Procedures Online . 2020;22 doi: 10.1186/s12575-019-0114-0.", "ArticleIdList": ["10.1186/s12575-019-0114-0", "PMC6995242", "32021568"]}, {"Citation": "Mulcahy E. Q. X., Col\u03ccn R. R., Abounader R. HGF/MET signaling in malignant brain tumors. International Journal of Molecular Sciences . 2020;21(20):p. 7546. doi: 10.3390/ijms21207546.", "ArticleIdList": ["10.3390/ijms21207546", "PMC7590206", "33066121"]}, {"Citation": "Labelle M., Begum S., Hynes R. O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell . 2011;20(5):576\u2013590.", "ArticleIdList": ["PMC3487108", "22094253"]}, {"Citation": "Schumacher D., Strilic B., Sivaraj K. K., Wettschureck N., Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell . 2013;24(1):130\u2013137. doi: 10.1016/j.ccr.2013.05.008.", "ArticleIdList": ["10.1016/j.ccr.2013.05.008", "23810565"]}, {"Citation": "Takagi S., Takemoto A., Takami M., Oh\u2010hara T., Fujita N. Platelets promote osteosarcoma cell growth through activation of the platelet\u2010derived growth factor receptor\u2010Akt signaling axis. Cancer Science . 2014;105(8):983\u2013988. doi: 10.1111/cas.12464.", "ArticleIdList": ["10.1111/cas.12464", "PMC4317862", "24974736"]}, {"Citation": "Takemoto A., Okitaka M., Takagi S., et al. A critical role of platelet TGF-\u03b2 release in podoplanin-mediated tumour invasion and metastasis. Scientific Reports . 2017;7(1):p. 42186. doi: 10.1038/srep42186.", "ArticleIdList": ["10.1038/srep42186", "PMC5297242", "28176852"]}, {"Citation": "Wei W., Rasul A., Sadiqa A., et al. Curcumol: from plant roots to cancer roots. International Journal of Biological Sciences . 2019;15(8):1600\u20131609. doi: 10.7150/ijbs.34716.", "ArticleIdList": ["10.7150/ijbs.34716", "PMC6643219", "31360103"]}, {"Citation": "Chen W., Lu Y., Gao M., Wu J., Wang A., Shi R. Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo. Journal of Ethnopharmacology . 2011;133(1):220\u2013226. doi: 10.1016/j.jep.2010.09.031.", "ArticleIdList": ["10.1016/j.jep.2010.09.031", "20920565"]}, {"Citation": "Lee Y.-C., Lin H.-H., Hsu C.-H., Wang C.-J., Chiang T.-A., Chen J.-H. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. European Journal of Pharmacology . 2010;632(1\u20133):23\u201332. doi: 10.1016/j.ejphar.2010.01.009.", "ArticleIdList": ["10.1016/j.ejphar.2010.01.009", "20097193"]}, {"Citation": "Sitohy B., Chang S., Sciuto T. E., et al. Early actions of anti-vascular endothelial growth factor/vascular endothelial growth factor receptor drugs on angiogenic blood vessels. American Journal of Pathology . 2017;187(10):2337\u20132347. doi: 10.1016/j.ajpath.2017.06.010.", "ArticleIdList": ["10.1016/j.ajpath.2017.06.010", "PMC5809587", "28736316"]}, {"Citation": "Chen J.-Y., Lai Y.-S., Chu P.-Y., Chan S.-H., Wang L.-H., Hung W.-C. Cancer-derived VEGF-C increases chemokine production in lymphatic endothelial cells to promote CXCR2-dependent cancer invasion and MDSC recruitment. Cancers . 2019;11(8):p. 1120. doi: 10.3390/cancers11081120.", "ArticleIdList": ["10.3390/cancers11081120", "PMC6721484", "31390756"]}, {"Citation": "Iwasaki T., Takeda Y., Maruyama K., et al. Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro. Journal of Biological Chemistry . 2013;288(4):2118\u20132131. doi: 10.1074/jbc.M112.424291.", "ArticleIdList": ["10.1074/jbc.M112.424291", "PMC3554885", "23223239"]}, {"Citation": "Jeong D., Watari K., Shirouzu T., et al. Studies on lymphangiogenesis inhibitors from Korean and Japanese crude drugs. Biological and Pharmaceutical Bulletin . 2013;36(1):152\u2013157. doi: 10.1248/bpb.b12-00871.", "ArticleIdList": ["10.1248/bpb.b12-00871", "23302649"]}, {"Citation": "Li D., Han T., Liao J., et al. Oridonin, a promising ent-kaurane diterpenoid lead compound. International Journal of Molecular Sciences . 2016;17(9):p. 1395. doi: 10.3390/ijms17091395.", "ArticleIdList": ["10.3390/ijms17091395", "PMC5037675", "27563888"]}, {"Citation": "Xu L., Bi Y., Xu Y., et al. Oridonin inhibits the migration and epithelial\u2010to\u2010mesenchymal transition of small cell lung cancer cells by suppressing FAK\u2010ERK1/2 signalling pathway. Journal of Cellular and Molecular Medicine . 2020;24(8):4480\u20134493. doi: 10.1111/jcmm.15106.", "ArticleIdList": ["10.1111/jcmm.15106", "PMC7176879", "32168416"]}, {"Citation": "Reno T. A., Kim J. Y., Raz D. J. Triptolide inhibits lung cancer cell migration, invasion, and metastasis. The Annals of Thoracic Surgery . 2015;100(5):1817\u20131825. doi: 10.1016/j.athoracsur.2015.05.074.", "ArticleIdList": ["10.1016/j.athoracsur.2015.05.074", "PMC4630145", "26298168"]}, {"Citation": "Li F., Cui H., Jin X., Gong X., Wang W., Wang J. Triptolide inhibits epithelial\u2011mesenchymal transition and induces apoptosis in gefitinib\u2011resistant lung cancer cells. Oncology Reports . 2020;43(5):1569\u20131579. doi: 10.3892/or.2020.7542.", "ArticleIdList": ["10.3892/or.2020.7542", "PMC7107945", "32323848"]}, {"Citation": "Zhang J., Wu C., Gao L., Du G., Qin X. Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects. Pharmacological Advances in Natural Product Drug Discovery . 2020;87:89\u2013112. doi: 10.1016/bs.apha.2019.08.002.", "ArticleIdList": ["10.1016/bs.apha.2019.08.002", "32089240"]}, {"Citation": "Cheng X., Gu J., Zhang M., et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-\u03b1-ERK1/2-NF-\u03baB pathway. International Immunopharmacology . 2014;23(1):304\u2013313. doi: 10.1016/j.intimp.2014.08.027.", "ArticleIdList": ["10.1016/j.intimp.2014.08.027", "25218161"]}, {"Citation": "Thibaut R., Bost P., Milo I., et al. Bystander IFN-\u03b3 activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nature cancer . 2020;1(3):302\u2013314. doi: 10.1038/s43018-020-0038-2.", "ArticleIdList": ["10.1038/s43018-020-0038-2", "PMC7115926", "32803171"]}, {"Citation": "Anichini A., Perotti V. E., Sgambelluri F., Mortarini R. Immune escape mechanisms in non small cell lung cancer. Cancers . 2020;12:p. 3605. doi: 10.3390/cancers12123605.", "ArticleIdList": ["10.3390/cancers12123605", "PMC7761620", "33276569"]}, {"Citation": "Liu J.-b., Chen D., Bao T.-t., Fan F.-t., Yu C. The anticancer effects of atractylenolide III associate with the downregulation of jak3/stat3-dependent Ido expression. Frontiers in Pharmacology . 2020;10:p. 1505. doi: 10.3389/fphar.2019.01505.", "ArticleIdList": ["10.3389/fphar.2019.01505", "PMC6983677", "32038231"]}, {"Citation": "Munn D. H., Mellor A. L. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunology . 2013;34(3):137\u2013143.", "ArticleIdList": ["PMC3594632", "23103127"]}, {"Citation": "Zhang A., Zheng Y., Que Z., et al. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with Ido. Journal of Cancer Research and Clinical Oncology . 2014;140(11):1883\u20131890. doi: 10.1007/s00432-014-1744-x.", "ArticleIdList": ["10.1007/s00432-014-1744-x", "24980548"]}, {"Citation": "Park H.-J., Chi G.-Y., Choi Y.-H., Park S.-H. Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization. Biochemical and Biophysical Research Communications . 2020;527(4):889\u2013895. doi: 10.1016/j.bbrc.2020.04.160.", "ArticleIdList": ["10.1016/j.bbrc.2020.04.160", "32430175"]}, {"Citation": "Sun C.-Y., Cao D., Ren Q.-N., et al. Combination treatment with inhibitors of ERK and autophagy enhances antitumor activity of betulinic acid in non-small-cell lung cancer in vivo and in vitro. Frontiers in Pharmacology . 2021;12:p. 684243. doi: 10.3389/fphar.2021.684243.", "ArticleIdList": ["10.3389/fphar.2021.684243", "PMC8275840", "34267658"]}, {"Citation": "Kommera H., Kalu\u0111erovi\u0107 G. N., Dittrich S., et al. Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity. Bioorganic & Medicinal Chemistry Letters . 2010;20(11):3409\u20133412. doi: 10.1016/j.bmcl.2010.04.004.", "ArticleIdList": ["10.1016/j.bmcl.2010.04.004", "20451375"]}, {"Citation": "Rzeski W., Stepulak A., Szyma\u0144ski M., et al. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology . 2006;374(1):11\u201320. doi: 10.1007/s00210-006-0090-1.", "ArticleIdList": ["10.1007/s00210-006-0090-1", "16964520"]}, {"Citation": "Hsu T.-I., Wang M.-C., Chen S.-Y., et al. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth. Molecular Pharmacology . 2012;82(6):1115\u20131128. doi: 10.1124/mol.112.078485.", "ArticleIdList": ["10.1124/mol.112.078485", "22956772"]}, {"Citation": "Kessler J. H., Mullauer F. B., de Roo G. M., Medema J. P. Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Letters . 2007;251(1):132\u2013145. doi: 10.1016/j.canlet.2006.11.003.", "ArticleIdList": ["10.1016/j.canlet.2006.11.003", "17169485"]}, {"Citation": "Saha S., Ghosh M., Dutta S. K. A potent tumoricidal co-drug \u201cBet-CA\u201d-an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells. Scientific Reports . 2015;5(1):p. 7762. doi: 10.1038/srep07762.", "ArticleIdList": ["10.1038/srep07762", "PMC4293591", "25585916"]}, {"Citation": "Zhan X. K., Li J. L., Zhang S., Xing P. Y., Xia M. F. Betulinic acid exerts potent antitumor effects on paclitaxel\u2011resistant human lung carcinoma cells (H460) via G2/M phase cell cycle arrest and induction of mitochondrial apoptosis. Oncology letters . 2018;16(3):3628\u20133634. doi: 10.3892/ol.2018.9097.", "ArticleIdList": ["10.3892/ol.2018.9097", "PMC6096078", "30127971"]}, {"Citation": "Li Q., Li Y., Wang X., et al. Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release. Molecular Carcinogenesis . 2011;50(10):760\u2013769. doi: 10.1002/mc.20673.", "ArticleIdList": ["10.1002/mc.20673", "21751259"]}, {"Citation": "Jin X., Yang Q., Cai N., Zhang Z. A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment. Nanomedicine . 2020;15(1):41\u201354. doi: 10.2217/nnm-2018-0479.", "ArticleIdList": ["10.2217/nnm-2018-0479", "31868113"]}, {"Citation": "Hsu Y.-L., Kuo P.-L., Lin C.-C. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sciences . 2004;75(10):1231\u20131242. doi: 10.1016/j.lfs.2004.03.008.", "ArticleIdList": ["10.1016/j.lfs.2004.03.008", "15219811"]}, {"Citation": "Wu S., Chen W., Liu K., et al. Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway. Journal of International Medical Research . 2020;48(9):p. 030006052093716. doi: 10.1177/0300060520937163.", "ArticleIdList": ["10.1177/0300060520937163", "PMC7780581", "32962498"]}, {"Citation": "Chen X., Liu C., Zhao R., et al. Synergetic and antagonistic molecular effects mediated by the feedback loop of p53 and JNK between saikosaponin D and SP600125 on lung cancer A549 cells. Molecular Pharmaceutics . 2018;15(11):4974\u20134984. doi: 10.1021/acs.molpharmaceut.8b00595.", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b00595", "30207732"]}, {"Citation": "Wang Q., Zheng X.-l., Yang L., et al. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. Journal of Experimental & Clinical Cancer Research . 2010;29(1):p. 159. doi: 10.1186/1756-9966-29-159.", "ArticleIdList": ["10.1186/1756-9966-29-159", "PMC3006358", "21143894"]}, {"Citation": "Tang J.-c., Long F., Zhao J., et al. The effects and mechanisms by which saikosaponin-D enhances the sensitivity of human non-small cell lung cancer cells to gefitinib. Journal of Cancer . 2019;10(26):6666\u20136672. doi: 10.7150/jca.30361.", "ArticleIdList": ["10.7150/jca.30361", "PMC6856895", "31777595"]}, {"Citation": "Shukla S., Sinha S., Khan S., et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/\u03b2-catenin signaling axis. Scientific Reports . 2016;6(1):p. 21860. doi: 10.1038/srep21860.", "ArticleIdList": ["10.1038/srep21860", "PMC4764833", "26905250"]}, {"Citation": "Lu P., Yu B., Xu J. Cucurbitacin B regulates immature myeloid cell differentiation and enhances antitumor immunity in patients with lung cancer. Cancer Biotherapy and Radiopharmaceuticals . 2012;27(8):495\u2013503. doi: 10.1089/cbr.2012.1219.", "ArticleIdList": ["10.1089/cbr.2012.1219", "22746287"]}, {"Citation": "Shukla S., Khan S., Kumar S., et al. Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis. Cancer Prevention Research . 2015;8(6):552\u2013562. doi: 10.1158/1940-6207.CAPR-14-0286.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0286", "25813524"]}, {"Citation": "Silva I. T., Geller F. C., Persich L., et al. Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549. Investigational New Drugs . 2016;34(2):139\u2013148. doi: 10.1007/s10637-015-0317-4.", "ArticleIdList": ["10.1007/s10637-015-0317-4", "26780083"]}, {"Citation": "Guo J., Wu G., Bao J., Hao W., Lu J., Chen X. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One . 2014;9(2):p. e88140. doi: 10.1371/journal.pone.0088140.", "ArticleIdList": ["10.1371/journal.pone.0088140", "PMC3913755", "24505404"]}, {"Citation": "Marostica L. L., Silva I. T., Kratz J. M., et al. Synergistic antiproliferative effects of a new cucurbitacin B derivative and chemotherapy drugs on lung cancer cell line A549. Chemical Research in Toxicology . 2015;28(10):1949\u20131960. doi: 10.1021/acs.chemrestox.5b00153.", "ArticleIdList": ["10.1021/acs.chemrestox.5b00153", "26372186"]}, {"Citation": "Yu B., Zheng L., Tang H., Wang W., Lin Y. Cucurbitacin B enhances apoptosis in gefitinib resistant non\u2011small cell lung cancer by modulating the miR\u201117\u20115p/STAT3 axis. Molecular Medicine Reports . 2021;24(4):p. 710. doi: 10.3892/mmr.2021.12349.", "ArticleIdList": ["10.3892/mmr.2021.12349", "PMC8383048", "34396444"]}, {"Citation": "Xu T., Jin Z., Yuan Y., et al. Ginsenoside Rg3 serves as an adjuvant chemotherapeutic agent and VEGF inhibitor in the treatment of non-small cell lung cancer: a meta-analysis and systematic review. Evidence-based Complementary and Alternative Medicine . 2016;2016:14. doi: 10.1155/2016/7826753.7826753", "ArticleIdList": ["10.1155/2016/7826753", "PMC5069366", "27800005"]}, {"Citation": "Peng Z., Wu W. W., Yi P. The efficacy of ginsenoside Rg3 combined with first-line chemotherapy in the treatment of advanced non-small cell lung cancer in China: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Pharmacology . 2021;11:p. 630825. doi: 10.3389/fphar.2020.630825.", "ArticleIdList": ["10.3389/fphar.2020.630825", "PMC8012535", "33815097"]}, {"Citation": "Li Y., Zhou T., Ma C., Song W., Zhang J., Yu Z. Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells. Journal of Thoracic Disease . 2015;7(3):400\u2013406. doi: 10.3978/j.issn.2072-1439.2015.01.03.", "ArticleIdList": ["10.3978/j.issn.2072-1439.2015.01.03", "PMC4387428", "25922718"]}, {"Citation": "Dai Y., Wang W., Sun Q., Tuohayi J. Ginsenoside Rg3 promotes the antitumor activity of gefitinib in lung cancer cell lines. Experimental and Therapeutic Medicine . 2019;17(1):953\u2013959. doi: 10.3892/etm.2018.7001.", "ArticleIdList": ["10.3892/etm.2018.7001", "PMC6307378", "30651886"]}, {"Citation": "Liu T.-G., Huang Y., Cui D.-D., et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer . 2009;9(1):p. 250. doi: 10.1186/1471-2407-9-250.", "ArticleIdList": ["10.1186/1471-2407-9-250", "PMC2721848", "19624862"]}, {"Citation": "Leem D. G., Shin J. S., Kim K. T., Choi S., Lee M. H., Lee K. T. Dammarane-type triterpene ginsenoside-Rg18 inhibits human non-small cell lung cancer A549 cell proliferation via G1 phase arrest. Oncology Letters . 2018;15(4):6043\u20136049. doi: 10.3892/ol.2018.8057.", "ArticleIdList": ["10.3892/ol.2018.8057", "PMC5844119", "29556318"]}, {"Citation": "Li H., Huang N., Zhu W., et al. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. BMC Cancer . 2018;18(1):p. 579. doi: 10.1186/s12885-018-4299-4.", "ArticleIdList": ["10.1186/s12885-018-4299-4", "PMC5963019", "29783929"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "3"}, {"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2021", "Month": "12", "Day": "1"}, {"Year": "2021", "Month": "12", "Day": "27", "Hour": "6", "Minute": "26"}, {"Year": "2021", "Month": "12", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["34956377", "PMC8702311", "10.1155/2021/3730963"]}}], "PubmedBookArticle": []}